Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Insights on the Use of JAK-inhibitors in Patients with Psoriatic Arthritis in an International Collaboration of Registers (the “JAK-pot” Study)

16/11/2023

Aymon R, Mongin D, Leeb B, Mustak-Blagusz M, Závada J, Pavelka K, Nordstrom D, Trokovic N, Iannone F, Codreanu C, Rotar Z, Kvien T, Provan S, Pombo Suarez M, Alonso F, Onen F, Inanc N, Coupal L, Choquette D, Lukina G, Elkayam O, Furer V, Rodrigues A, COURVOISIER D, Finckh A, Nissen M, Lauper K

ACR 2023

Aymon R, Mongin D, Leeb B, Mustak-Blagusz M, Závada J, Pavelka K, Nordstrom D, Trokovic N, Iannone F, Codreanu C, Rotar Z, Kvien T, Provan S, Pombo Suarez M, Alonso F, Onen F, Inanc N, Coupal L, Choquette D, Lukina G, Elkayam O, Furer V, Rodrigues A, COURVOISIER D, Finckh A, Nissen M, Lauper K. Insights on the Use of JAK-inhibitors in Patients with Psoriatic Arthritis in an International Collaboration of Registers (the “JAK-pot” Study) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/insights-on-the-use-of-jak-inhibitors-in-patients-with-psoriatic-arthritis-in-an-international-collaboration-of-registers-the-jak-pot-study/

https://acrabstracts.org/abstract/insights-on-the-use-of-jak-inhibitors-in-patients-with-psoriatic-arthritis-in-an-international-collaboration-of-registers-the-jak-pot-study/